Dapagliflozin in combination therapy for treating type 2 diabetes

Technology appraisal guidance
Reference number: TA288
Published: 26 June 2013
Last updated: 23 November 2016

Evidence

Supporting evidence

Review decision
Review decision - July 2016
Review decision - January 2015
Appendix A - RPP decision paper - August 2015 (PDF 197 KB)

Published:

02 November 2015
Review decision - August 2015